Robert Hershberg's Net Worth

$5.55 Million

Estimate Recalculated May 20, 2025 11:47PM EST

Who is Robert Hershberg

Robert Hershberg has an estimated net worth of $5.55 Million. This is based on reported shares across multiple companies, which include Adaptive Biotechnologies Corp, RECURSION PHARMACEUTICALS, INC., NanoString Technologies Inc, FATE THERAPEUTICS INC, Silverback Therapeutics, Inc., HilleVax, Inc., and DENDREON CORP.

SEC CIK

Robert Hershberg's CIK is 0001274139

Past Insider Trading and Trends

2020 was Robert Hershberg's most active year for acquiring shares with 23 total transactions. Robert Hershberg's most active month to acquire stocks was the month of May. 2020 was Robert Hershberg's most active year for disposing of shares, totalling 50 transactions. Robert Hershberg's most active month to dispose stocks was the month of January. 2020 saw Robert Hershberg paying a total of $212,004.96 for 191,217 shares, this is the most they've acquired in one year. In 2020 Robert Hershberg cashed out on 125,226 shares for a total of $2,419,425.59, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Adaptive Biotechnologies Corp

Investor
Updated Mar 06, 2024
Form 4
104.48%
79.37K
Mar 06, 2024
155.34K
Grant
Mar 04
Form 4
62.27%
38.10K
Mar 08, 2023
99.30K
Grant
Mar 06
Form 4
$0.45
$23.85K
Feb 03, 2023
61.19K
Options
Feb 02
Form 4
1,556.58%
23.41K
Jan 28, 2022
24.92K
Grant
Jan 26
Form 4
-3.64%
-2.00K
$22.51
-$88.22K
Mar 10, 2021
53.00K
Sale
ScheduledMar 08
Form 4
-3.54%
-2.00K
$22.51
-$88.22K
Mar 10, 2021
54.50K
Sale
ScheduledMar 08
Form 4
5.72%
3.26K
$32.95
-$130.00K
Feb 17, 2021
60.26K
Sell-Options
ScheduledFeb 14 - Feb 16
Form 4
-3.39%
-2.00K
$33.51
-$132.22K
Jan 20, 2021
57.00K
Sale
ScheduledJan 15
Form 4
-3.28%
-2.00K
$28.19
-$110.96K
Dec 16, 2020
59.00K
Sale
ScheduledDec 15
Form 4
-3.17%
-2.00K
$24.07
-$94.48K
Nov 18, 2020
61.00K
Sale
ScheduledNov 16
Form 4
-3.08%
-2.00K
$25.98
-$102.12K
Oct 16, 2020
63.00K
Sale
ScheduledOct 15
Form 4
-2.99%
-2.00K
$21.52
-$84.26K
Sep 16, 2020
65.00K
Sale
ScheduledSep 15
Form 4
-2.90%
-2.00K
$19.92
-$77.87K
Aug 19, 2020
67.00K
Sale
ScheduledAug 17
Form 4
-2.82%
-2.00K
$22.15
-$86.79K
Jul 17, 2020
69.00K
Sale
ScheduledJul 15
Form 4
-2.74%
-2.00K
$21.73
-$85.10K
Jun 17, 2020
71.00K
Sale
ScheduledJun 15
Form 4
-2.67%
-2.00K
$17.60
-$68.60K
May 18, 2020
73.00K
Sale
ScheduledMay 15
Form 4
-25.00%
-25.00K
$15.11
-$733.00K
Apr 27, 2020
75.00K
Sale
ScheduledApr 23
Form 4
8.89K
Feb 18, 2020
8.89K
Grant
Feb 13
Form 3
Jun 26, 2019
Showing 19 results

RECURSION PHARMACEUTICALS, INC.

Investor
Updated Jun 05, 2024
Form 4
101.74%
39.29K
Jun 05, 2024
77.91K
Grant
Jun 03
Form 4
145.48%
37.84K
Jun 21, 2023
637.63K
Grant
Jun 16
Form 4
692.38%
54.44K
Jun 16, 2022
599.80K
Grant
Jun 14
Form 4
9.67%
693.00
Jan 05, 2022
7.86K
Grant
Jan 03
Form 4
8.67%
572.00
Oct 05, 2021
7.17K
Grant
Oct 01
Form 4
5.55%
347.00
Jul 06, 2021
6.60K
Grant
Jul 01
Form 4
Apr 22, 2021
543.75K
Options
Apr 20
Form 4
18.75K
Apr 19, 2021
543.75K
Grant
Apr 15 - Apr 16
Form 3
Apr 15, 2021
Showing 9 results

NanoString Technologies Inc

Investor
Updated Apr 18, 2022
Form 4
Apr 18, 2022
11.30K
Options
Apr 18
Form 4
52.50%
3.89K
Jun 17, 2021
11.30K
Options
Jun 15 - Jun 16
Form 4
-1.48%
-144.00
$29.51
-$10.64K
Apr 19, 2021
9.57K
Sale
ScheduledApr 15
Form 4
-44.25%
-1.50K
$39.07
-$83.61K
Mar 17, 2021
1.89K
Sale
ScheduledMar 15
Form 4
-25.95%
-1.19K
$28.49
-$95.48K
Feb 18, 2021
3.39K
Sale
ScheduledFeb 16
Form 4
-24.68%
-1.50K
$26.56
-$108.92K
Jan 19, 2021
4.58K
Sale
ScheduledJan 15
Form 4
-19.79%
-1.50K
$25.74
-$103.99K
Dec 16, 2020
6.08K
Sale
ScheduledDec 15
Form 4
-16.52%
-1.50K
$20.07
-$70.00K
Nov 18, 2020
7.58K
Sale
ScheduledNov 16
Form 4
-14.18%
-1.50K
$18.24
-$59.02K
Oct 16, 2020
9.08K
Sale
ScheduledOct 15
Form 4
-12.42%
-1.50K
$19.31
-$65.43K
Sep 17, 2020
10.58K
Sale
ScheduledSep 15
Form 4
-11.05%
-1.50K
$17.99
-$57.55K
Aug 19, 2020
12.08K
Sale
ScheduledAug 17
Form 4
-9.95%
-1.50K
$17.44
-$54.22K
Jul 17, 2020
13.58K
Sale
ScheduledJul 15
Form 4
24.25%
4.02K
$14.23
-$57.39K
Jun 17, 2020
20.60K
Sell-Options
ScheduledJun 15 - Jun 16
Form 4
-100.00%
-10.17K
$13.31
-$313.43K
May 18, 2020
Sale
ScheduledMay 15
Form 4
5.75K
Jun 20, 2019
5.75K
Grant
Jun 18
Form 4
4.41K
Mar 27, 2019
4.41K
Grant
Mar 25
Form 4
10.17K
Jan 03, 2018
10.17K
Grant
Jan 01
Form 4
8.61K
Jan 04, 2017
8.61K
Grant
Jan 01
Form 4
7.83K
Jan 05, 2016
7.83K
Grant
Jan 01
Form 4
14.69K
Mar 03, 2015
14.69K
Grant
Mar 02
Form 3
Mar 03, 2015
Showing 21 results

FATE THERAPEUTICS INC

Investor
Updated Jun 07, 2023
Form 4
40.00K
Jun 07, 2023
40.00K
Grant
Jun 06
Form 4
1,022.55%
20.54K
Jun 13, 2022
22.55K
Grant
Jun 09
Form 4
-25.07%
-672.00
$22.75
-$15.29K
Jun 06, 2022
2.01K
Sale
Jun 03
Form 4
7.01K
Jun 04, 2021
7.02K
Grant
Jun 02
Form 4
40.00K
May 05, 2020
40.00K
Grant
May 01
Form 3
May 05, 2020
Showing 6 results

Silverback Therapeutics, Inc.

Investor
Updated Jun 13, 2022
Form 4
18.00K
Jun 13, 2022
18.00K
Grant
Jun 10
Form 4
15.00K
Sep 21, 2021
15.00K
Grant
Jun 04
Form 4
73.25K
Dec 07, 2020
73.25K
Grant
Dec 03
Form 3
Dec 03, 2020
Showing 4 results

HilleVax, Inc.

See Remarks
Updated Feb 12, 2024
Form 4
40.34%
389.49K
$14.93
-$173.16K
Feb 12, 2024
1.35M
Grant
Feb 08
Form 4
73.30%
569.92K
Feb 03, 2023
1.35M
Grant
Feb 01
Form 3
Apr 28, 2022
777.46K
Showing 3 results

DENDREON CORP

Sr. VP & Chief Medical Officer
Updated Jan 23, 2006
Form 4
251.45%
11.25K
$5.50
$61.88K
Jan 23, 2006
15.72K
Grant
Jan 19
Form 4
22.50K
Dec 15, 2005
22.50K
Grant
Dec 13
Form 4
75.00K
Dec 10, 2004
75.00K
Grant
Dec 08
Form 4
35.00K
Dec 22, 2003
35.00K
Grant
Dec 18
Form 3
Dec 22, 2003
Showing 5 results